All vaccines that are authorised by regulatory authorities come with important safety information that should be carefully ...

V116 (PCV21) was more cost-effective than PCV20 alone and PCV15 plus PPSV23 for the prevention of adult pneumococcal disease.

Timely vaccination is essential to ensure babies develop sufficient immunity against potentially deadly diseases. Hence, it ...

The Centers for Disease Control and Prevention (CDC) now recommends that American adults over the age of 50 receive the ...

Pfizer’s latest-generation pneumococcal conjugate vaccine is in line to reach more people in Latin America and the Caribbean ...

Changes to both schedules include new and updated recommendations for COVID-19 vaccine, change to trivalent influenza vaccines ...

Vaxcyte's robust financial position supports its strategic flexibility and extended timelines. Read more to see why I rate ...

Pneumococcal Vaccine market Forecast to Surge to US$ 14.43 Billion by 2032, Achieving a Remarkable 6.4% CAGR ...

At the 116,865 pre-travel visits, 25% of travelers were eligible to receive the pneumococcal vaccine, but only 68% of the ...

While changes in cost varied by vaccine, the average overall inflation-adjusted private-sector costs climbed 0.9% and 1.4% ...

Pneumococcal Vaccination Recall Program for adults aged 70 years and older, a simple QI activity to enhance patient care through a free patient ...

Short-term apnea is more common among hospitalized preterm infants who receive their 2-month vaccines compared with those who ...